Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
Shintaro Takaki, Akihito Tsubota, Tetsuya Hosaka, Norio Akuta, Takashi Someya, Masahiro Kobayashi, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu KumadaVolume:
39
Language:
english
Pages:
6
DOI:
10.1007/s00535-003-1363-9
Date:
July, 2004
File:
PDF, 209 KB
english, 2004